Account Management Training & Oncology Account Management Training
Tuesday, November 05, 2019 - Thursday, November 07, 2019
Coronado Island Marriott Resort & Spa
The Account Management Training (AMT) program is a comprehensive, hands-on training event designed to provide the Life Sciences Industry with the knowledge, techniques, and confidence to successfully work with their customers.
The 2019 fall course will run with a parallel track specifically focused on Oncology: Oncology Account Management Training (OAMT). The OAMT program is available for those working specifically with oncology customers.
Participants can choose to attend the Core Payer Curriculum or the Oncology Curriculum
Need additional help validating your attendance at the Account Management Training program? Download our justification letter today!
Jim Kenney is the Former Manager, Specialty and Pharmacy Contracts at Harvard Pilgrim Health Care, a full-service health benefits company located in Wellesley, MA. Harvard serves more than 1.25 million commercial and Medicare Part D members, has achieved the highest accreditation from the National Committee for Quality Assurance, and was ranked as the No. 1 health plan in America for 10 consecutive years. Mr Kenney has been with Harvard for over 34 years and has held several positions including Staff Pharmacist, Chief Pharmacist, Assistant Administrator for Pharmacy Programs, and Pharmacy Operations Manager. Currently, Mr Kenney has corporate responsibility for the pharmacy contracting program with pharmaceutical manufacturers and specialty pharmacy providers in support of a budget of over $700 million. He is also a member of the pharmacy and therapeutics committee.
His accomplishments include the creation and management of the network pharmacy program for the group practice model of Harvard, the development of the pharmacy rebate program, creation of the Medicare Part D contracting program, and co-leading the Pharmacy Materials Management System Project. Mr Kenney developed the specialty pharmacy program at HPHC for injectables, as well as a second program in support of infertility management.
Mr Kenney is a pharmacy preceptor for the Massachusetts College of Pharmacy and Allied Health Sciences. He currently serves on the Massachusetts Pharmacists Association Government and Legislative Affairs Committee. Mr Kenney is also an active member of the Academy of Managed Care Pharmacy, having served on multiple committees and also as a peer reviewer for the academy journal. He serves on the Academy board of directors.
Sheila Arquette is the Executive Director of the National Association of Specialty Pharmacy. She holds a Bachelor of Science degree in Pharmacy from the State University of New York at Buffalo School of Pharmacy. She has extensive practical and leadership experience in retail pharmacy, hospital pharmacy, long-term care consulting and dispensing, in addition to the managed care, PBM and specialty pharmacy space. She is a regular speaker and participant at national pharmacy conferences, roundtables and industry meetings.
Sheila comes to NASP from Independent Health where she was the Director of Pharmacy Services.
Sheila has served on the NASP membership committee and as the co-chair of the Government Affairs Committee. She was elected to the NASP Board of Directors and received the NASP Distinguished Service Award in September 2016. She also is a long- standing member of AMCP.
Mark Garnett is the Market Lead for the southeastern division of Cigna-HealthSpring, a Medicare Advantage company that helps seniors navigate the turbulent waters of health insurance. Mr Garnett's 91-year-old mother is a Cigna-HealthSpring member, which is one of the many reasons he's passionate about helping seniors improve their quality of life in a time when most have been left to fend for themselves. Having spent the first 20+ years of his career in the pharma industry (trainer, manager, director, account manager) and the past 6 on the payer side of health insurance, he possesses a unique ability to see and convey a variety of Medicare-related information (Part C and D benefit design, Star Quality Program, Part D Contracting, the Low-Income Subsidy, dual-eligible beneficiaries) using a conversational, common-sense approach.
Dr Adaora Oraefo is a native of Raleigh, NC, and currently resides in the Atlanta, GA, area. Dr Oraefo attended the University of North Carolina at Chapel Hill, where she earned her Bachelor of Science in Biology and a minor in Chemistry, as well as her Doctor of Pharmacy. She also received a Masters of Science in Clinical Research from Campbell University. She has experience in various areas of the pharmaceutical and biotechnology sectors. Prior to joining Optum/UnitedHealthcare, Dr Oraefo served as a Pharmacy Operations Manager at Kaiser Permanente, where she was responsible for pharmacy operations for a facility serving thousands of local patients. She managed a staff of pharmacists, pharmacy technicians, and other support personnel.
Dr Oraefo has a passion for education and a desire to ensure all Americans receive equal access to healthcare, with a particular focus on older adults. She began working as the clinical pharmacist supporting the Georgia, Arkansas, and Alabama for the Medicare & Retirement markets of UnitedHealthcare with their pharmacy quality strategy, the first role of its kind in Optum/UnitedHealthcare. She regularly engages with providers, members, as well as chain and independent pharmacies to drive strategy that improves medication adherence and decreases the use of high-risk medications for older adults.
Dr Oraefo also serves as chief executive officer of Lavish Affairs, a family owned event planning company, and WanderEvol, LLC, a travel concierge company, and is the chief executive officer of Adaora Oraefo Consulting Group, LLC.
Currently, Dr Oraefo is a Pharmacy Associate Director for the Georgia and Alabama markets with responsibility to drive pharmacy strategy. This includes working with providers, members and both independent and chain pharmacies to achieve success in Part D measures. She enjoys traveling, reading, cooking, and most especially spending time with her son, Kene, the love of her life.
Jayson S Slotnik is a Principal and founding member of Health Policy Strategies, Inc, a Washington, DC–based consulting firm representing innovative biotech, pharmaceutical, device, and diagnostic companies. Mr Slotnik specializes in, and counsels clients on, the impact Medicare and Medicaid coverage, payment, reimbursement, coding, and government policies have on commercial success. He also has experience as a healthcare strategist, with demonstrated success in developing and implementing both pre- and post-launch strategies as well as life-cycle management tools for pharmaceutical, biotechnology, diagnostic, and device manufacturers.
Prior to establishing Health Policy Strategies, Inc, Mr Slotnik served as the Vice President of Reimbursement and Innovation Strategies for United BioSource Corporation (UBC). There, he was responsible for developing technology-related marketing and sales strategies for current internal and new external customers in the branded specialty pharmaceutical space. He partnered with the business development team to market technology strategies to over 20 branded specialty manufacturers. In addition, he maintained his policy practice, which helped distinguish UBC’s market access technology as well as affording his clients the ability to have the business drive the policy, and not the reverse.
Before joining UBC, Mr Slotnik practiced law at 2 prominent Washington, DC, law firms, where he counseled clients on many complex healthcare regulatory and legal issues related to coverage, coding, and reimbursement. Before returning to private practice, he served as the initial Director of Medicare Reimbursement and Economic Policy at the Biotechnology Industry Organization (BIO), the industry’s leading advocacy group. Mr Slotnik served as the liaison between BIO and Congress, Centers for Medicare & Medicaid Services (CMS), and other federal agencies to implement market access policies that stimulate and reward innovation while maintaining appropriate patient access to cutting edge therapies.
Mr Slotnik serves on the editorial boards for Value-Based Cancer Care and Specialty Pharmacy Times. He speaks regularly at various healthcare reform and market access conferences. Mr Slotnik received a BA degree in English from the University of Rochester, his Master in Public Health with a concentration in Epidemiology and Biostatistics from George Washington University, and his Juris Doctor degree in Health Law from the University of Maryland School of Law.
As Chief Medical Officer for EmpiraMed Inc, Neil B. Minkoff is working to develop the PRO Portal for capturing self-reported patient outcomes and clinical information in an effort to measure real-world comparative effectiveness.
Dr Minkoff has served as commissioner of the Massachusetts Group Insurance Commission, which provides oversight of health insurance for the Commonwealth of Massachusetts, and has served as medical director for network medical management and pharmacy for Harvard Pilgrim Health Care. Previously, he was associate medical director of Partners Community Healthcare, a large integrated provider network; was co-chair of medical management and P&T for the CareGroup Network; and was medical director for Waltham Hospital.
Dr Minkoff founded FountainHead HealthCare in 2010 as a reaction to the complexity of the healthcare system and the need for independent thinkers who could provide some clarity in the chaos.
Dr Minkoff attended Bowdoin College, where he graduated summa cum laude in history; was awarded his MD from Dartmouth Medical School; and received an Executive Education Certificate from the Wharton School at the University of Pennsylvania. He trained in internal medicine at the Lahey Clinic and practiced as an internist. Dr Minkoff was awarded a Bronze United States Congressional Medal in 1986. He served as co-chair of AHIP's Specialty Pharmaceuticals Workgroup and is a frequent contributor to NPR and National Review.
Following a 32-year career in Virginia state government, Patrick Finnerty formed his own consulting firm, PWF Consulting, which provides consulting services to several healthcare organizations. During his government career, Mr Finnerty was appointed by 2 governors to serve as Virginia's Medicaid Director, from 2002 to 2010. In this role, he directed all aspects of Virginia's Medicaid and Children's Health Insurance Programs. At the time of his retirement from state government, the Virginia Medicaid and CHIP programs served over 820,000 persons and had a total budget of nearly $7 billion.
Prior to his appointment as Medicaid Director, Mr Finnerty worked for the Virginia General Assembly's Joint Commission on Health Care. As the Commission's Executive Director, he had overall responsibility for the Commission's healthcare policy analyses and studies, and directed the Commission's legislative agenda. Before the Joint Commission on Health Care, he was director of the Virginia state employee health benefits program for 4 years. In this position, he managed 2 statewide health benefits programs for more than 150,000 persons.
Winston Wong, PharmD, is the President of the W-Squared Group. The W-Squared Group is committed to assist healthcare innovators develop their value statement, and then launch their technology in the government and commercial marketplace. Dr. Wong is also the current Editor-In-Chief for the Journal of Clinical Pathways, a journal committed to providing high-quality educational and informational articles as well as presenting original health economic outcomes research data to an audience of leaders in pathway development, commercial payers, reimbursement specialists, ACO oncologists, oncology practice managers, and cancer center directors.
Throughout his 30-year career in the pharmacy industry, he has been repeatedly recognized for his clinical and business innovations. Dr. Wong’s accomplishments start with his leading of two separate hospital pharmacy departments “out of the basement”, to having a more active clinical role in patient care areas. This new role of the hospital pharmacist was then implemented on a regional basis through his work accomplished at the Southern New England Region of VHA, then the largest Group Purchasing Organization in the United States. His entry into managed care was in 1994, joining United HealthCare, where he developed the first Senior Prescription Benefit offering, which was in place until the CMS Medicare Part D benefit was implemented in 2006.
During his past 17 years as the Associate Vice President of Pharmacy Management at CareFirst BlueCross BlueShield, from which he retired in the fall of 2013, he was responsible for the development, implementation, and administration of the prescription benefit, including formulary development, contracting, including the Medicare Part D prescription benefit. As part of the Part D benefit, he was instrumental in the development and implementation of a pharmacist driven Medication Therapy Management (MTM) program that has been recognized by CMS, and many national organizations.
Dr. Wong also implemented one of the first successful network-based oncology treatment pathway program, a Pay-for-Quality program in which oncologists collaborated with the health plan to comply with specific treatment pathways for specific cancer types while meeting specific clinical and quality metrics. Under Dr. Wong’s leadership, the model was expanded into rheumatology and gastroenterology. In June 2019, Dr. Wong was named as one of the Top 100 Healthcare Leaders in 2018 by the International Forum on Advancement in Healthcare.
He earned his PharmD degree in 1981 from the University of the Pacific in Stockton, California, and completed a General Residency at the University of Nebraska Hospital and Clinics in Omaha, Nebraska.
Dr Cortas is a member of the American Society of Clinical Oncology and American Society of Hematology. In 2008, she served as director of the multidisciplinary thoracic oncology program at the VA medical center in Cleveland. In addition, Dr Cortas was appointed director of the inpatient oncology unit. She was then appointed associate chairperson of the cancer center committee and the coordinator of quality of cancer registry. Dr Cortas served as assistant professor of internal medicine at Case Western Reserve University. In addition, she was appointed as staff member in the internal medicine department at the Louis Stokes VA Medical Center division of Hematology/Oncology with responsibilities including patient care, teaching medical students, residents, and fellows.
Dr Cortas earned her medical degree at the American University of Beirut in Lebanon in 2001. She completed her residency in internal medicine, and fellowship in hematology and oncology at Case Western Reserve University/University Hospitals of Cleveland. Dr Cortas was appointed assistant professor of internal medicine at Case Western Reserve University.
Dr Cortas joined Arizona Oncology in January 2011. She treats thoracic, gastrointestinal, breast, malignancies, lymphomas, and benign blood disorders. Dr Cortas has great interest in women’s malignancies. She is head of Arizona Oncology’s Phoenix area breast cancer clinical trials.
As the Vice President of the Midwest Business Group on Health (MBGH), Ms Larson leads its educational and networking activities focused on health-benefits management, health improvement, and healthcare reform. Additionally, she oversees several major employer research projects, including National Employer Initiative on Specialty Pharmacy, Value-Based Benefit Design Research Series, and Preventive Benefits and the Affordable Care Act. Founded in 1980, MBGH is a leading national-employer coalition, with over 120 self-insured public and private employers represented by human resources/benefits professionals; collectively, its members provide healthcare benefits to more than 4 million individuals.
Ms Larson joined MBGH in 1983 and served as the Director of Membership Development. In 1996, she went on to work for a population health management company, serving as the Director of Employer Services. She returned to MBGH in 2006. She is a national speaker on MBGH research, offering expertise on employer best practices in value-based benefits, incentives, consumerism, engagement, wellness, communications, and biologic/specialty drug management.
She currently serves as a member of the Advisory Council of the Center for Employee Health Studies at the University of Illinois/Chicago School of Public Health and in recent years has served on various industry boards.
Bryan Reindl is the Project Manager for the Northern Division of Arizona Oncology. His responsibilities include Creation, Implementation, and continued support of CMMI’s Oncology Care Model; Director of Coding; and Director of Compliance. His most notable recent achievement is the creation of Arizona Oncology’s Cancer Survivorship Program.
Bryan has been working in healthcare for over 18 years (since 2000). In 2004, he graduated with a Bachelor of Science degree from Grand Canyon University, and has been in a healthcare management role for 13 years (since 2005).
Over the years, Bryan received formalized trainings and certifications as a Professional Coder, Medical Compliance Officer, and Physician Practice Manager, which includes the specialties of Plastic & Reconstructive Surgery, Hand & Microsurgery, Colorectal Surgery, ENT, and Oncology.
Professionally, Bryan is passionate about developing new innovative healthcare programs, feels that simplicity is the key to success, and believes in the power of humor as a training tool.
In addition to Bryan’s great smile, you can find him on a bike as a Certified Spinning Instructor. He enjoys spending time with his husband at ANY Southern California beach. Bryan is also a dog-lover at heart, and is thrilled to be here as a part of this exciting adventure!
Sneha Sharma has over 10 years of pharmacy experience and leadership in various areas of specialized pharmacy. Most recently she has been involved in managed care pharmacy with focus on specialty drugs. Key accomplishments include: developing tools and implementing metrics to monitor operational performance, clinical review, supporting performance improvement initiatives, and research projects. Research included NIH Study on Compliance and Adherence for transplant patients.
2000 Second Street | Coronado, California 92118 | (619) 435-3000
Coronado Island Marriott Resort & Spa offers an idyllic retreat; with views of the San Diego skyline and Coronado Bridge, the hotel is ideally situated to provide easy access to Coronado Beach and San Diego attractions, including the Gaslamp District and Balboa Park. Take advantage of the hotel’s renovated wellness center, luxury spa, outdoor pools, delicious restaurants, and our proximity to waterfront activities.
We are pleased to offer a group rate of $239 per night for AMT attendees. Book your group rate for AMT Training Meeting! Reservations can also be made by calling 1-800-228-9290 or (619) 435-3000 and mentioning Decision Resources.
Attendance is limited to ensure maximum participation.
Your registration fee includes:
- "Getting Ready for Account Management Training: A Primer on the Basics," an interactive PDF pre-read
- Customizable Managed Markets Survival Kit
- PDFs of the presentations
- Breakfast, lunch, and refreshment breaks daily
- Evening networking reception
Early Bird Special:
Take advantage of the $500 discount by registering on or before October 15, 2019. The early bird special rate is only $2,795 per attendee.
Register 3 or more colleagues and take advantage of special group pricing. The more colleagues that register, the more you save!
|Registrants||Before October 16||On/After October 16|
|10+||Contact TrainingSolutions@teamDRG.com for additional group discount offers.|
- All payments must be received prior to the program
- Please make all checks payable to: DR/Decision Resources, LLC
- All cancellations are subject to a $200 cancellation fee
- No refunds will be granted after October 18, 2019
- Canceled registrations and/or no-shows will not be carried over to future programs